The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frontline brentuximab vedotin in Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma for older patients and those with comorbidities.
 
Christopher A. Yasenchak
Honoraria - Seagen; Takeda
Speakers' Bureau - BeiGene
Research Funding - Seagen
 
Rodolfo Eduardo Bordoni
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Merck
(OPTIONAL) Uncompensated Relationships - Practice Point Communications
 
Victor Y. Yazbeck
Consulting or Advisory Role - Celgene; Gilead Sciences; Seagen
 
Dipti Patel-Donnelly
Research Funding - Boston Biomedical (Inst); Gilead Sciences (Inst); LAM Therapeutics (Inst); Roche (Inst)
 
Tim Larson
No Relationships to Disclose
 
Robert Brownell Sims
Employment - Seagen
Stock and Other Ownership Interests - Seagen
Travel, Accommodations, Expenses - Seagen
 
Matthew Genyeh Mei
Consulting or Advisory Role - Sanofi